6 Matching Annotations
  1. May 2024
  2. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Neoadjuvant radiotherapy in ER+, HER2+, and triple-negative -specific breast cancer based humanized tumor mice enhances anti-PD-L1 treatment efficacy
    1
    1. scibot 15 May 2024
      AB_2563852

      DOI: 10.3389/fimmu.2024.1355130

      Resource: (BioLegend Cat# 329714, RRID:AB_2563852)

      Curator: @scibot

      SciCrunch record: RRID:AB_2563852

      What is this?
      RRID:AB_2563852
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11089195/
  3. Apr 2024
  4. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    ISG12a promotes immunotherapy of HBV-associated hepatocellular carcinoma through blocking TRIM21/AKT/β-Catenin/PD-L1 axis
    1
    1. scibot 10 Apr 2024
      RRID:AB_2563852

      DOI: 10.1016/j.isci.2024.109533

      Resource: (BioLegend Cat# 329714, RRID:AB_2563852)

      Curator: @scibot

      SciCrunch record: RRID:AB_2563852

      What is this?
      RRID:AB_2563852
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11000115/
  5. Feb 2024
  6. www.sciencedirect.com www.sciencedirect.com
    PD-L1-expressing tumor-associated macrophages are immunostimulatory and associate with good clinical outcome in human breast cancer
    1
    1. scibot 21 Feb 2024
      RRID:AB_2563852

      DOI: 10.1016/j.xcrm.2024.101420

      Resource: (BioLegend Cat# 329714, RRID:AB_2563852)

      Curator: @scibot

      SciCrunch record: RRID:AB_2563852

      What is this?
      RRID:AB_2563852
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666379124000430
  7. www.sciencedirect.com www.sciencedirect.com
    SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion
    1
    1. scibot 02 Feb 2024
      RRID:AB_2563852

      DOI: 10.1016/j.cell.2024.01.008

      Resource: (BioLegend Cat# 329714, RRID:AB_2563852)

      Curator: @scibot

      SciCrunch record: RRID:AB_2563852

      What is this?
      RRID:AB_2563852
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S0092867424000102
  8. Jan 2024
  9. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity
    1
    1. scibot 05 Jan 2024
      RRID:AB_2563852

      DOI: 10.1158/1535-7163.MCT-23-0118

      Resource: (BioLegend Cat# 329714, RRID:AB_2563852)

      Curator: @evieth

      SciCrunch record: RRID:AB_2563852

      What is this?
      RRID:AB_2563852
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10762337/
  10. Nov 2017
  11. www.sciencedirect.com www.sciencedirect.com
    Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors
    1
    1. scibot 08 Nov 2017
      AB_2563852

      Curator: @gabimpine

      Resource used:

      (BioLegend Cat# 329714, RRID:AB_2563852)

      SciCrunch record: RRID:AB_2563852

      Alternate resolvers: SciCrunch xml N2T identifiers.org

      What is this?

      RRID:AB_2563852 RRIDCUR:Validated
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S0092867416312442